RxDoctor Payments Data

Charles Davidson, MD

Family Medicine · Walnut Ridge, ARNPI 1457425902

Payments from drug & device makers

$1,386in general payments, 2019–2025

Across 31 payments — averaging $44.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$868
  • Amgen$284
  • Abbott$173
  • Novartis$23
  • GSK$13
  • Novo Nordisk$13
  • plus $13 from 1 others

What the payments were for

  • Travel & lodging$69950%
  • Food & beverage$68750%

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences4$868
Amgen20$284
Abbott2$173
Novartis2$23
GSK1$13
Novo Nordisk1$13
Astellas Pharma US Inc1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,386 in reported general payments places this provider in the 65th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$21,509
Medicare patients
161
Services billed
2,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$72,747
JardianceEmpagliflozin28$24,206
XareltoRivaroxaban28$15,111
EliquisApixaban16$14,766
Tresiba Flextouch U-200Insulin Degludec11$9,742
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,322
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen285$3,702
Novolin RInsulin Regular, Human24$3,213
Albuterol Sulfate HfaAlbuterol Sulfate63$2,038
Atorvastatin Calcium300$1,902
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,875
Potassium Chloride146$1,784
Gabapentin131$1,694
Omeprazole199$1,651
Glipizide ErGlipizide105$1,629

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$72,74762 claims
GSKTrelegy Ellipta$13$7,32212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Walnut Ridge

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →